Successful treatment of SAPHO syndrome (chronic nonbacterial osteomyelitis and acne) with anakinra and denosumab. Case report and review of therapy.

Adam, Zdenek; Sedivá, Anna; Zeman, David; Fojtík, Zdenek; Petrásová, Hana; Diatková, Jana; Tomíska, Miroslav; Král, Zdenek; Treglerová, Jana; Perina, Vojtech; Kamaradová, Katerina; Adamová, Zdenka; Pour, Ludek

Adam, Zdenek; Sedivá, Anna; Zeman, David; Fojtík, Zdenek; Petrásová, Hana; Diatková, Jana; Tomíska, Miroslav; Král, Zdenek; Treglerová, Jana; Perina, Vojtech; Kamaradová, Katerina; Adamová, Zdenka; Pour, Ludek.

Vnitr Lek ; 69(E-5): 4-14, 2023.

Article in En | MEDLINE | ID: mdl-37827817

Subject(s)

Acne Vulgaris; Acquired Hyperostosis Syndrome; Osteomyelitis; Male; Humans; Adult; Acquired Hyperostosis Syndrome/complications; Acquired Hyperostosis Syndrome/drug therapy; Acquired Hyperostosis Syndrome/diagnosis; Interleukin 1 Receptor Antagonist Protein/therapeutic use; Denosumab/therapeutic use; Fluorodeoxyglucose F18/therapeutic use; Osteomyelitis/drug therapy; Osteomyelitis/complications; Osteomyelitis/microbiology; Acne Vulgaris/complications; Acne Vulgaris/diagnosis

Key words

Osteomyelitis; SAPHO syndrome; anakinra; denosumab; multiple bone osteolysis; osteitis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteomyelitis / Acne Vulgaris / Acquired Hyperostosis Syndrome Limits: Adult / Humans / Male Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google